Dr. Sarah Braunstein oversees New York City’s response to the HIV epidemic and serves as the Bureau’s Director of HIV Epidemiology, leading and providing scientific direction to a large program with a wide-ranging portfolio of HIV epidemiology and research projects. She oversees the collection, management, analysis, and dissemination of data from New York City’s HIV surveillance registry; HIV partner services, linkage to care, and care reengagement for people with diagnosed HIV and their partners; and Centers for Disease Control and Prevention-sponsored and other HIV clinical, behavioral, and health disparities-focused research. Dr. Braunstein has extensive background and training in epidemiologic methods and implementation science, having conducted domestic and international clinical studies and epidemiologic research on the prevention and epidemiology of HIV and other sexually transmitted infections for over 20 years.
At the completion of this educational session, participants will:
1. Understand the foundations of HIV surveillance and the status of the HIV epidemic in New York City.
2. Learn about the intersection between HIV and COVID-19 in the New York City population.
3. Understand the growing evidence base related to higher risk for adverse COVID-19-related outcomes among people with HIV.
This CME activity has approved for
AMA PRA Category 1 Credit™ for April 14, 2021 as a live activity. This activity will also be available as an enduring activity from April 15, 2021, through April 13, 2024.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Policies and standards of the Medical Society of the State of New York and the Accreditation Council for Continuing Medical Education require that speakers and planners for continuing medical education activities disclose any relevant financial relationships they may have with commercial interests whose products, devices, or services may be discussed in the content of a CME activity.
- Dr. James F. Braun, DO (Course Director) has no relevant financial relationships to disclose.
- Dr. William M. Valenti (Moderator) has no relevant financial relationships to disclose.
- Dr. Braunstein will support her presentation and clinical recommendations with the best available evidence from the medical literature and will submit her slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; Merck & Co.; and ViiV Healthcare
Click here to take the CME Evaluation and Post-Meeting Evaluation
Download Article PDF/Slides